Lexicon Pharmaceuticals, Inc. (LXRX) was a big mover last session with its shares rising nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend of the company as the stock has lost almost 4% in the past one-month time frame.
This biotechnology company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Lexicon currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Investors interested in the biomedical industry may also consider stocks like Actelion Ltd. (ALIOF), Biogen Idec Inc. (BIIB) and Osiris Therapeutics, Inc. (OSIR). All the three stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
LEXICON PHARMACEUTICALS INC (LXRX): Free Stock Analysis Report
ACTELION LTD (ALIOF): Free Stock Analysis Report
BIOGEN IDEC INC (BIIB): Free Stock Analysis Report
OSIRIS THERAPEUTICS MD (OSIR): Free Stock Analysis Report
Zacks Investment Research